Driving CARs with alternative navigation tools – the potential of engineered binding scaffolds-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Driving CARs with alternative navigation tools – the potential of engineered binding scaffolds

Published:2020-08-31 Issue:7 Volume:288 Page:2103-2118
ISSN:1742-464X
Container-title:The FEBS Journal
language:en
Short-container-title:FEBS J

Author:

Zajc Charlotte U.¹²^ORCID,Salzer Benjamin¹³^ORCID,Taft Joseph M.⁴,Reddy Sai T.⁴,Lehner Manfred¹³⁵^ORCID,Traxlmayr Michael W.¹²^ORCID

Affiliation:

1. Christian Doppler Laboratory for Next Generation CAR T Cells Vienna Austria

2. Department of Chemistry Institute of Biochemistry BOKU‐University of Natural Resources and Life Sciences Vienna Austria

3. St. Anna Children’s Cancer Research Institute Vienna Austria

4. Department of Biosystems Science and Engineering ETH Zurich Basel Switzerland

5. Department of Pediatrics St. Anna KinderspitalMedical University of Vienna Austria

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/febs.15523

Reference112 articles.

1. Chimeric Antigen Receptor Therapy

2. Chimeric antigen receptor–modified T cells: CD19 and the road beyond

3. CAR T‐cells: an exciting frontier in cancer therapy;The Lancet;Lancet,2017

4. Chimeric antigen receptor T-cell therapy — assessment and management of toxicities

5. Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small molecule-regulated switches to provide functional control of CAR T cells within the patient;Expert Opinion on Biological Therapy;2024-06-02

2. Nanobody-based CAR NK cells for possible immunotherapy of MICA+ tumors;PNAS Nexus;2024-04-30

3. An engineering strategy to target activated EGFR with CAR T cells;Cell Reports Methods;2024-04

4. Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances;Journal of Controlled Release;2024-04

5. MICA-specific nanobodies for diagnosis and immunotherapy of MICA+ tumors;Frontiers in Immunology;2024-03-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3